Alere Cholestech Ldx
Payments companies reported to CMS as associated with Alere Cholestech Ldx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alere Cholestech Ldx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alere Cholestech Ldx
These are the largest totals companies reported as associated with Alere Cholestech Ldx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Richman | Huntington Beach, CA | Endocrinology, Diabetes & Metabolism | $15,525.00 |
| Barry Gorlitsky | Greenville, SC | Nephrology (Internal Medicine) | $2,125.00 |
| Christopher Defilippi | Baltimore, MD | Cardiovascular Disease | $2,100.00 |
| Joseph Kvedar | Boston, MA | Dermatology | $1,400.00 |
| Michael Fine | Laguna Beach, CA | $1,193.94 | |
| Michael Ackerman | Warrenton, VA | Internal Medicine | $815.24 |
| Olugbemiga Jegede | Greensboro, NC | Internal Medicine | $721.51 |
| Aaron King | San Antonio, TX | Family Medicine | $677.03 |
| Eden Miller | Bend, OR | Family Medicine | $448.69 |
| Michael Kobernick | Warren, MI | Emergency Medicine | $182.45 |
Prescribed Alere Cholestech Ldx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.